Prof. Dr. LÜTFİYE MÜLAZİMOĞLU DURMUŞOĞLU

Metrikler

Yayın

105

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

2865

H-İndeks (WoS)

Atıf (Scopus)

3598

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Eğitim Bilgileri

1994 - 1995

Yüksek Lisans

Pittsburg State University, Amerika Birleşik Devletleri

1987 - 1991

Tıpta Uzmanlık

Diğer (Kurumlar,hastaneler Vb.), Hastaneler, İstanbul Taksim Eğitim Ve Araştırma Hastanesi, Türkiye

1979 - 1985

Lisans

İstanbul Üniversitesi, Tıp Fakültesi, Türkiye

Yaptığı Tezler

1991

Tıpta Uzmanlık

DOĞURGANLIKDA LISTERIA MONOCYTOGENES

Diğer (Kurumlar,hastaneler Vb.)

Yabancı Diller

C2 Ustalık

Almanca

C1 İleri

İngilizce

Araştırma Alanları

Tıp

Yaşam Bilimleri

Akademik Ünvanlar / Görevler

2002 - Devam Ediyor

Prof. Dr.

Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

Yönetimsel Görevler

2024 - Devam Ediyor

Anabilim/Bilim Dalı Başkanı

Marmara Üniversitesi

2023 - Devam Ediyor

Mezuniyet Sonrası Eğitim Sorumlusu

Marmara Üniversitesi

2015 - Devam Ediyor

Bölüm Kalite Komisyonu Üyesi

Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

Akademi Dışı Deneyim

1994 - 1995

Post Doc Fellow

Pittsburgh University, Post Doc Fellow

Yönetilen Tezler

2016

Tıpta Uzmanlık

Yoğun bakımda yatan ventilatör ilişkili pnömoni hastalarında pentraxin, prokalsitonin ve C-reaktif protein düzeylerinin karşılaştırılması

DURMUŞOĞLU L. (Danışman)

H.BİLGİN(Öğrenci)

Eğitim Altyapısı Bilgileri

Eylül 2019

Biosafety and Biosecurity Training Laboratory

Laboratuvar

Gargılı Keleş A., Omurtag Korkmaz B. İ., Durmuşoğlu L.

Makaleler

2025

1. Sexual behaviours and sexually transmitted infections among MSM living with HIV followed at a university hospital in Istanbul, Turkey

Yağçı Çağlayık D., Doganc F. B., Can R., Ersoy D. M., Soyletir G., Sili U., et al.

International Journal of STD and AIDS , 2025 (SCI-Expanded, Scopus)

2024

2. Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission

Tazegül G., Aydın V., Tükenmez Tigen E., Erturk Sengel B., Köksal K., Doğan B., et al.

TURKISH JOURNAL OF INTERNAL MEDICINE , cilt.6, sa.3, ss.144-154, 2024 (Hakemli Dergi)

2023

3. Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.

SİLİ U., AY P., TOPUZOGLU A., BİLGİN H., TİGEN E. T., ŞENGEL B. E., et al.

Infectious diseases & clinical microbiology , cilt.5, sa.2, ss.94-105, 2023 (TRDizin)

2023

4. Development and Evaluation of Combined Effect Buccal Films for Treatment of Oral Candidiasis

Arslan D., AKBAL DAĞISTAN Ö., SAĞIRLI A. O., DURMUŞOĞLU L., CEVHER E., Yildiz-Pekoz A.

AAPS PharmSciTech , cilt.24, sa.1, 2023 (SCI-Expanded)

2023

5. Anatomi Laboratuvarında Biyogüvenlik

GÜNGÖRDÜ B., MÜLAZİMOĞLU DURMUŞOĞLU L.

ASOS Yayinevi , cilt.1, ss.23-27, 2023 (Hakemli Dergi)

2022

6. Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis

Yildiz Pekoz A., Akbal Dagistan O., Fael H., Culha M., Erturk A., Basarir N. S., et al.

DRUG DELIVERY , cilt.29, sa.1, ss.2846-2854, 2022 (SCI-Expanded)

2022

7. Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects

Akbal-Dagistan O., Sevim M., Sen L. S., Basarir N. S., Culha M., Erturk A., et al.

PHARMACEUTICS , cilt.14, sa.11, 2022 (SCI-Expanded)

2022

8. The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-gamma release by natural killer cells

Bilgin H., Marku M., Yilmaz S. S., Karahasan Yagci A., Sili U., Can B., et al.

VACCINE , cilt.40, sa.18, ss.2619-2625, 2022 (SCI-Expanded, Scopus)

2020

9. A new scoring system for early diagnosis of ventilator-associated pneumonia: LUPPIS

Haliloglu M., Bilgili B., Bilginer H., Kasapoglu U. S., Sayan I., Aslan M. S., et al.

ARCHIVES OF MEDICAL SCIENCE , cilt.16, sa.5, ss.1040-1048, 2020 (SCI-Expanded)

2020

10. Antimicrobial Resistance and Molecular Patterns in Community-acquired Complicated Intra-abdominal Infections: A Multicentric Study

AVKAN OĞUZ V., BAYKAM N., KORTEN V., MADINA A., YAPAR D., DURMUŞOĞLU L., et al.

Infectious Diseases and Clinical Microbiology , cilt.2, sa.2, ss.71-77, 2020 (Hakemli Dergi)

2020

11. Oral tablet formulations containing cyclodextrin complexes of poorly water soluble cefdinir to enhance its bioavailability

Morina D., Sessevmez M., SİNANİ G., Mulazimoglu L., Cevher E.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.57, 2020 (SCI-Expanded)

2020

12. Kemik İliği Transplantasyonunda Enfeksiyon Profilaksisi ve Post-Transplant Aşılamalar

TİGEN E., DURMUŞOĞLU L.

Türkiye Klinikleri Sağlık Bilimleri Dergisi , 2020 (Hakemli Dergi)

2020

13. Antibiotic resistance rates in Enterococcus spp. in Turkey; a meta-analysis research

Cetinkaya R. A., Yenilmez E., Mulazimoglu L.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.11, ss.7-14, 2020 (ESCI)

2018

14. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery

Yildiz-Pekoz A., Akbal O., Tekarslan S. H., SAĞIRLI A. O., Mulazimoglu L., Morina D., et al.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY , cilt.31, sa.6, ss.347-357, 2018 (SCI-Expanded)

2018

15. Influence of multidrug resistant organisms on the outcome of diabetic foot infection

Saltoglu N., Ergonul O., Tulek N., Yemisen M., Kadanali A., Karagoz G., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.70, ss.10-14, 2018 (SCI-Expanded)

2018

16. Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections

Aydin M., Ergonul O., Azap A., Bilgin H., Aydin G., Cavus S. A., et al.

JOURNAL OF HOSPITAL INFECTION , cilt.98, sa.3, ss.260-263, 2018 (SCI-Expanded)

2018

17. Sequential Measurements of Pentraxin 3 Serum Levels in Patients with Ventilator-Associated Pneumonia: A Nested Case-Control Study

Bilgin H., Haliloglu M., Yaman A., Ay P., BİLGİLİ B., ARSLANTAŞ M. K., et al.

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY , cilt.2018, 2018 (SCI-Expanded)

2017

18. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections

Koksal I., YILMAZ G., ÜNAL S., Zarakolu P., KORTEN V., Mulazimoglu L., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , cilt.72, sa.5, ss.1364-1372, 2017 (SCI-Expanded)

2016

19. Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality

Ergonul O., Aydin M., Azap A., Basaran S., Tekin S., Kaya S., et al.

JOURNAL OF HOSPITAL INFECTION , cilt.94, sa.4, ss.381-385, 2016 (SCI-Expanded)

2016

20. ORTOPEDİK ENFEKSİYONLARDA LABARATUVAR MİKROBİYOLOJİK TANI VE ANTİBİYOTİK

TİGEN E., MULAZIMOĞLU DURMUŞOĞLU L.

TÜRKİYE KLİNİKLERİ , 2016 (Hakemli Dergi)

2015

21. Diagnosis, Treatment and Prevention of Diabetic Foot Wounds and Infections: Turkish Consensus Report

Saltoglu N., Kilicoglu O., Baktiroglu S., Osar-Siva Z., Aktas S., Altindas M., et al.

KLIMIK JOURNAL , cilt.28, sa.1, ss.2-34, 2015 (ESCI)

2015

22. Delftia acidovorans: A rare pathogen in immunocompetent and immunocompromised patients

Bilgin H., Sarmis A., TİGEN E., Soyletir G., Mulazimoglu L.

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY , cilt.26, sa.5, ss.277-279, 2015 (SCI-Expanded)

2015

23. Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey

Saltoglu N., Yemisen M., Ergonul O., Kadanali A., Karagoz G., Batirel A., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.21, sa.7, ss.659-664, 2015 (SCI-Expanded)

2014

24. Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.

Tigen E., Tandogdu Z., Ergonul O., Altinkanat G., Gunaydin B., Ozgen M., et al.

Urology , cilt.84, sa.5, ss.1008-15, 2014 (SCI-Expanded)

2014

25. Outcomes of Fecal Carriage of Extended-spectrum b-Lactamase After Transrectal Ultrasound-guided Biopsy of the Prostate COMMENT Reply

TİGEN E., Tandogdu Z., Ergonul O., ALTINKANAT GELMEZ G., Gunaydin B., Ozgen M., et al.

UROLOGY , cilt.84, sa.5, ss.1014-1015, 2014 (SCI-Expanded)

2014

26. EXPERIMENTAL EVALUATION OF TIGECYCLINE AND TEIKOPLANIN IN THE TREATMENT OF IMPLANT RELATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OSTEOMYELITIS

Orhan Z., Degirmenci E., Oktas B., Karaduman O., Kir G., DURMUŞOĞLU L.

INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH , cilt.5, sa.10, ss.4566-4573, 2014 (Hakemli Dergi)

2014

27. Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis

Cevher E., Acma A., Sinani G., Aksu B., Zloh M., Mulazimoglu L.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , cilt.69, ss.124-136, 2014 (SCI-Expanded)

2014

28. A prospective study: inflammation, infection and comorbidity in patients on long-term dialysis.

Akbaş T., Mülazımoğlu L., Aksu B., Akoğlu E.

Journal of renal care , cilt.40, ss.6-13, 2014 (SCI-Expanded)

2014

29. Reports of four cyst hydatid cases in different size and location

Tukenmez Tigen E., ERTÜRK ŞENGEL B., Bilgin H., Ozel S., Mulazimoglu L.

Asian Pacific Journal of Tropical Disease , cilt.4, sa.5, ss.408-411, 2014 (Scopus)

2013

30. Impact of fecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae on the outcomes of transrectal needle biopsies of the prostate Geniş spektrumlu beta laktamaz üreten enterobacteriaceae taşi{dotless}yi{dotless}ci{dotless}li{dotless}ǧi{dotless}ni{dotless}n prostate{dotless}n transrectal iǧne biyopsisi sonuçlarna etkisi

Tükenmez Tigen E., Ergönül Ö., Altinkanat G., Özgen M., Ertük Şengel B., ODABAŞI Z., et al.

Marmara Medical Journal , cilt.26, sa.3, ss.127-129, 2013 (ESCI)

2012

31. Concomitant use of N-acetylcysteine and reduction of amphotericin B-induced nephrotoxicity

Sengel B. E., Tigen E., Kaygusuz I., Cafer A., Toptas T., Kantarcioglu B., et al.

MYCOSES , cilt.55, ss.121, 2012 (SCI-Expanded)

2012

32. Extended Spectrum Lactamases and Their Clinical Importance in Community Acquired Infections

TİGEN E., DURMUŞOĞLU L.

KLIMIK JOURNAL , cilt.25, sa.3, ss.94-98, 2012 (Scopus)

2010

33. Severe respiratory failure secondary to Varicella zoster pneumonia

ERYÜKSEL E., ABUL Y., KARAKURT S., AKBAŞ T., DURMUŞOĞLU L., ÇELİKEL T. H.

Journal of Clinical and Experimental Investigations , cilt.1, sa.2, ss.113-116, 2010 (Hakemli Dergi)

2010

34. Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis

ORHAN Z., Cevher E., Yildiz A., Ahiskali R., Sensoy D., Muelazimoglu L.

ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY , cilt.130, sa.1, ss.135-142, 2010 (SCI-Expanded)

2008

35. Preparation and characterisation of natamycin: gamma-cyclodextrin inclusion complex and its evaluation in vaginal mucoadhesive formulations

Cevher E., Sensoy D., Zloh M., Mulazimoglu L.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.97, sa.10, ss.4319-4335, 2008 (SCI-Expanded)

2007

36. A case of Budd-Chiari syndrome with Behcet's disease and oral contraceptive usage

Akbas T., Imeryuez N., Bayalan F., Baltacioglu F., Ataguenduez P., Muelazimoglu L., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.28, sa.1, ss.83-86, 2007 (SCI-Expanded)

2007

37. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004-2005

Sener B., Tunckanat F., Ulusoy S., Tuenger A., Soeyletir G., Muelazimoglu L., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , cilt.60, sa.3, ss.587-593, 2007 (SCI-Expanded)

2007

38. In vitro susceptibility of respiratory isolates of streptococcus pneumoniae and streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of E-Baskett-II Surveillance Study

Gur D., Mulazimoglu L., Unal S.

MIKROBIYOLOJI BULTENI , cilt.41, sa.1, ss.1-9, 2007 (SCI-Expanded)

2007

39. Antibiotic Usage Policies

DURMUŞOĞLU L.

JOURNAL OF THE TURKISH SOCIETY OF INTENSIVE CARE-TURK YOGUN BAKM DERNEGI DERGISI , cilt.5, sa.1, ss.21-22, 2007 (ESCI)

2007

40. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: Preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis

Cevher E., Orhan Z., Sensoy D., Ahiskali R., Kan P. L., Sagirli O., et al.

JOURNAL OF MICROENCAPSULATION , cilt.24, sa.6, ss.577-595, 2007 (SCI-Expanded)

2006

41. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres

Cevher E., Orhan Z., Mulazimoglu L., Sensoy D., Alper M., Yildiz A., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.317, sa.2, ss.127-135, 2006 (SCI-Expanded)

2006

42. The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres - Their evaluation in an animal osteomyelitis model

Orhan Z., Cevher E., Mulazimoglu L., Gurcan D., Alper M., Araman A., et al.

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME , sa.2, ss.270-275, 2006 (SCI-Expanded)

2006

43. Antibiotics are not needed during tube thoracostomy for spontaneous pneumothorax: an observational case study

Olgac G., Aydogmus U., Mulazimoglu L., Kutlu C. A.

JOURNAL OF CARDIOTHORACIC SURGERY , cilt.1, 2006 (SCI-Expanded)

2005

44. Rhodotorula minuta: uncommon yeast isolated as the causative agent of a right hip joint infection

Cerikcioglu N., Tetik C., Mulazimoglu L.

JOURNAL DE MYCOLOGIE MEDICALE , cilt.15, sa.1, ss.52-55, 2005 (SCI-Expanded)

2004

45. Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum beta-lactamases

Paterson D., Ko W., Von Gottberg A., Mohapatra S., Casellas J., Goossens H., et al.

CLINICAL INFECTIOUS DISEASES , cilt.39, sa.1, ss.31-37, 2004 (SCI-Expanded)

2004

46. International prospective study Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial infections

Paterson D., Ko W., Von Gottberg A., Mohapatra S., Casellas J., Goossens H., et al.

ANNALS OF INTERNAL MEDICINE , cilt.140, sa.1, ss.26-32, 2004 (SCI-Expanded)

2003

47. An unusual native tricuspid valve endocarditis caused by Candida colliculosa

Kaygusuz I., Mulazimoglu L., Cerikcioglu N., Toprak A., Oktay A., Korten V.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.9, sa.4, ss.319-322, 2003 (SCI-Expanded)

2003

48. Antibiotic prophylaxis in elective thoracic surgery: Cefuroxime versus cefepime

Turna A., Kutlu C., Ozalp T., Karamustafaoglu A., Maulazimoglu L., Bedirhan M.

THORACIC AND CARDIOVASCULAR SURGEON , cilt.51, sa.2, ss.84-88, 2003 (SCI-Expanded)

2002

49. Community-acquired Klebsiella pneumoniae bacteremia: Global differences in clinical patterns

Ko W., Paterson D., Sagnimeni A., Hansen D., Von Gottberg A., Mohapatra S., et al.

EMERGING INFECTIOUS DISEASES , cilt.8, sa.2, ss.160-166, 2002 (SCI-Expanded)

2001

50. Can Legionnaires disease be diagnosed by clinical criteria? A critical review

Mulazimoglu L., Yu V.

CHEST , cilt.120, sa.4, ss.1049-1053, 2001 (SCI-Expanded)

2001

51. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory

Paterson D., Ko W., Von Gottberg A., Casellas J., Mulazimoglu L., Klugman K., et al.

JOURNAL OF CLINICAL MICROBIOLOGY , cilt.39, sa.6, ss.2206-2212, 2001 (SCI-Expanded)

2001

52. Treatment of community-acquired pneumonia in hospitalised patients

Mulazimoglu L.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , cilt.18, 2001 (SCI-Expanded)

2000

53. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia

Paterson D., Mulazimoglu L., Casellas J., Ko W., Goossens H., Von Gottberg A., et al.

CLINICAL INFECTIOUS DISEASES , cilt.30, sa.3, ss.473-478, 2000 (SCI-Expanded)

1997

54. Comparison of two DNA extraction methods on inhibitory sputum samples [8]

Vahaboglu H., Avkan V., Dodanli S., Uzun M., Yildirim I., Mulazimoglu L.

Clinical Microbiology and Infection , cilt.3, sa.1, ss.144-145, 1997 (SCI-Expanded)

1996

55. In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis

Mulazimoglu L., Drenning S., Yu V.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.40, sa.10, ss.2428-2430, 1996 (SCI-Expanded)

1996

56. Vancomycin-gentamicin synergism revisited: Effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus

Mulazimoglu L., Drenning S., Muder R.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.40, sa.6, ss.1534-1535, 1996 (SCI-Expanded)

1995

57. RESISTANCE TO EXTENDED-SPECTRUM CEPHALOSPORINS, CAUSED BY PER-1 BETA-LACTAMASE, IN SALMONELLA-TYPHIMURIUM FROM ISTANBUL, TURKEY

VAHABOGLU H., HALL L., MULAZIMOGLU L., DODANLI S., YILDIRIM I., LIVERMORE D.

JOURNAL OF MEDICAL MICROBIOLOGY , cilt.43, sa.4, ss.294-299, 1995 (SCI-Expanded)

1990

58. RELIABILITY OF RAPID UREASE TEST

VAHABOGLU H., ARIKAN E., MULAZIMOGLU L.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY , cilt.94, sa.6, ss.802-803, 1990 (SCI-Expanded)

1900

59. Ortopedik Enfeksiyonlarda Laboratuar Mikrobiolojik Tanı ve Antibiotik Tedavisi

TİGEN E., DURMUŞOĞLU L.

Turkiye Klinikleri Journal of Medical Sciences , cilt.9, sa.4, 1900 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

2021

1. Murphy Vakaları: 3 Ardışık Sino-Orbital-Serebral Mukormikoz

Alhan Ö., Özalp B., ERDİL E., DEMİR B., DERİCİOĞLU V., ÇERMAN E., et al.

XXI. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, Türkiye, 26 - 30 Mayıs 2021, ss.512-513, (Özet Bildiri)

2020

2. FACTORS ASSOCIATED WITH PROGRESSION TO CRITICAL ILLNESS IN 28 DAYS AMONG COVID-19 PATIENTS: RESULTS FROM A TERTIARY CARE HOSPITAL IN ISTANBUL, TURKEY (00734 )

SİLİ U., AY N. P., TOPUZOĞLU A., BİLGİN H., TİGEN E., ERTÜRK ŞENGEL B., et al.

ECCVID CONFERENCE ON CORONAVIRUS DISEASE, İsviçre, 23 - 25 Eylül 2020, (Tam Metin Bildiri)

2019

3. Tedavisi zor nadir bir olgu: Sol orbital apeks sendromu bulguları ile başvuran rinoserebral mukormikoz

Erdil E., TUNÇ H., ERDEM S. N., ALHAN Ö., Mülazimoğlu L., KAHRAMAN KOYTAK P., et al.

55. Ulusal Nöroloji Kongresi, Türkiye, 15 - 21 Kasım 2019, (Özet Bildiri)

2019

4. Üç Ardışık Sinoorbital Mukormikoz Olgusu

ALHAN Ö., ÖZALP B., ERDİL E., DERİCİOĞLU V., DEMİR B., GÜL F., et al.

5. Ulusal Klinik Mikrobiyoloji Kongresi, Türkiye, 28 Ekim - 01 Kasım 2019, (Özet Bildiri)

2019

5. Factors associated with progression to critical illness in 28 days among COVID-19 patients: results from a tertiary care hospital in Istanbul, Turkey

SİLİ U., BİLGİN H., TİGEN E., DURMUŞOĞLU L., KORTEN V.

ECCVID 2020, İsviçre, 22 - 25 Eylül 2019, (Tam Metin Bildiri)

2019

6. İmmunsupresif Hastada Posakonazol Profilaksisi Altında Gelişen Akciğer Lezyonu: Mukormikoz muydu?

ALHAN Ö., KOYUNCUER A., ÇERİKÇİOĞLU N., Mülazımoğlu L.

XX. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi (KLİMİK 2019) 13-16 Mart 2019 Antalya, 13 - 16 Mart 2019, ss.563-564, (Tam Metin Bildiri)

2017

7. Diagnostic value of pentraxin 3 in ventilator associated pneumonia

BİLGİN H., CİNEL İ. H., BİLGİLİ B., HAKLAR G., AY P., DURMUŞOĞLU L.

ECCMID 2016, 09 Ocak 2017 - 12 Nisan 2016, (Tam Metin Bildiri)

2016

8. Epidemiology and antimicrobial resistance patterns of community acquired complicated intra abdominal infections the data from three tertiary hospitals in Turkey

AVKAN OĞUZ V., BAYKAM N., KORTEN V., YAPAR N., DURMUŞOĞLU L., abdulleyava m.

ECCMID 2016, 9 - 12 Nisan 2016, (Özet Bildiri)

2016

9. Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi 2012-2015 Candida Türleri Antifungal Duyarlılığı

ERTÜRK ŞENGEL B., Mülazımoğlu L., ÇERİKÇİOĞLU N., SÖYLEDİR G., KORTEN V.

KLİMİK 2016 - 30. YIL KURUKTAYI, Antalya, Türkiye, 9 - 12 Mart 2016, ss.413-415, (Özet Bildiri)

2016

10. Atipik radyolojik bulgular ile seyreden subakut pulmoner aspergilloz Olgu

Karakadıoğlu S., Tekin A., TİGEN E., DURMUŞOĞLU L.

KLİMİK kongresi, Türkiye, 9 - 12 Mart 2016

Kitaplar

2022

1. Tıpta ve Enfeksiyon Hastalıklarında Yapay Zekâ

Durmuşoğlu L. (Editör), Altıkardeş Z. A. (Editör)

Türkiye Klinikleri Yayınevi, Ankara, 2022

2022

2. Enfeksiyon Hastalıklarında ve Tıpta Yapay Zekânın Yeri Ne Olmalı? Genç Bakış

Durmuşoğlu L.

Tıpta ve Enfeksiyon Hastalıklarında Yapay Zekâ, Lütfiye Mülazımoğlu Durmuşoğlu,Zehra Aysun Altıkardeş, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.50-54, 2022

2022

3. ENFEKSİYON HASTALIKLARINDA VE TIPTA YAPAY ZEKANIN YERİ NE OLMALI-GENÇ BAKIŞ

DİLARA U., MÜLAZİMOĞLU DURMUŞOĞLU L.

TIPTA VE ENFEKSİYON HASTALIKLARINDA YAPAY ZEKA, LÜTFİYE MÜLAZIMOĞLU DURMUŞOĞLU, ZEHRA AYSUN ALTIKARDEŞ, Editör, TÜRKİYE KLİNİKLERİ YAYAIN SERİ NO 1254-ORTADOĞU REKLAM TANITIM YAYINCILIK ANKARA, İstanbul, ss.50-54, 2022

2015

4. AĞRISIZ EKLEMLER

ONDER O., MÜLAZIMOĞLU L.

KURALDIŞI, 2015

2015

5. ALERJİYE SON

ÖNDER Ö., MULAZIMOGLU L.

KURALDIŞI, 2015

2005

6. Macrolides

Durmuşoğlu L.

Antimicrobial Chemotherapy And Vaccineses, Yu VL,Edwards G,McKinnon PS,Peloquin C,Morse D., Editör, eSun Technologies, Pennsylvania, ss.243-279, 2005

2001

7. Legionellosis

Durmuşoğlu L.

Current Therapy in Infectious Diseases, Second Edition , Schlossberg D., Editör, Mosby-Year Book, Inc. , Missouri, ss.427-429, 2001

1999

8. Macrolides

Durmuşoğlu L.

Antimicrobial Chemotherapy A.nd Vaccines , Baltimore,USA 1999;795-820, Yu Vl,Merigan TC,Barriere SL, Editör, Lippincott Williams & Wilkins , Maryland, ss.795-782, 1999

1997

9. Legionellosis

Durmuşoğlu L.

3. Mülazımoğlu L, Yu VL. Legionellosis in: Current Therapy in Adult Medicine, Eds. Kassirer JP, Greene II HL. Mosby Year Book Inc., Philadelphia, USA 1997, 267-268, Kassirer JP,Greene II HL., Editör, Mosby-Year Book, Inc. , Pennsylvania, ss.267-268, 1997

1997

10. LEGIONELLA INFECTIONS

Durmuşoğlu L.

HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, Fauci AS,Braunwald E,Isselbacher Kj,Wilson JD,Martin JB,Kasper DL,Hauser SL,Longo DL., Editör, McGraw-Hill Medical Publishing Division , New York, ss.928-933, 1997

1996

11. Macrolides in Ear, Nose and Throat Infections

Durmuşoğlu L.

Infectious Diseases and Antimicrobial Therapy in Ear, Nose, Throat. , Johnston JT,Yu VL., Editör, W. B. Saunders Company (US) , Pennsylvania, ss.100-108, 1996

Desteklenen Projeler

2019 - 2019